GRC 8200

· Glenmark Pharmaceuticals Europe Ltd. (R&D)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GRC 8200, covering 2009-09-24 to 2009-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus [Phase 2]